CONMED Corporation Financial Ratios
CNMD / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
4.5%
ROE ranks in the below average among Health Care companies
Profit Margin
3.4%
Net Income / Revenue
Asset Turnover
0.59
Revenue / Total Assets
Equity Multiplier
2.25
Total Assets / Equity
Composite: 4.6% (reported: 4.5%)
Profitability
Liquidity
Current Ratio
2.14
Quick Ratio
1.01
Solvency
Interest Coverage
5.49
Efficiency
Asset Turnover
0.59
Inventory Turnover
1.76
Days Sales Outstanding
66 days
As of FY2025 · SEC 10-K · Updated Jul 4, 2026
Earnings Quality
Accrual Ratio
-5.3%
-3.8pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.